Susquehanna International Group, LLP Pro Phase Labs, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 102,015 shares of PRPH stock, worth $35,705. This represents 0.0% of its overall portfolio holdings.
Number of Shares
102,015
Previous 74,012
37.84%
Holding current value
$35,705
Previous $29,000
34.48%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding PRPH
# of Institutions
34Shares Held
2.68MCall Options Held
12.3KPut Options Held
0-
Sykon Capital LLC Harrison, NY645KShares$225,6780.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$142,8930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA259KShares$90,6720.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL229KShares$80,3080.0% of portfolio
-
Quinn Opportunity Partners LLC Charlottesville, VA218KShares$76,3440.01% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $5.61M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...